Erratum: Author correction to "Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers" [Acta Pharmaceutica Sinica B 11 (2021) 355-372].

ABSTRACT: [This corrects the article DOI: 10.1016/j.apsb.2020.05.004.].

SUBMITTER: Jiang T 

PROVIDER: S-EPMC9214051 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature